Another concern in difficult-to-control hypothyroidism is the management of patients who remain symptomatic despite presenting with serum thyroid hormone levels within the recommended goals, raising considerations about the benefits of combined LT4/LT3 therapy in this situation. The gene discussed is TG; the disease is hypothyroidism.